Chances are you probably overlooked this big-picture figure prior to Tilray’s initial public offering.
Dealmaking has also sent pot stocks soaring. Major alcohol companies, Big Tobacco, and even pharmaceutical companies are looking to partner with the cannabis industry for a taste of this rapid growth. The biggest tie-up to date involves a $3.8 billion equity investment in Canopy Growth Corp. by Corona and Modelo beer producer Constellation Brands.
Did you overlook this jaw-dropping statistic in Tilray’s prospectus?
But in recent months, no stock has captivated the marijuana investors more than medical cannabis grower Tilray (NASDAQ:TLRY). What’s truly amazing about Tilray is that it hasn’t even been a publicly traded company for two months, yet it’s seemingly risen through the ranks as investors’ favorite pot stock. Since pricing its shares at $17 on July 18, Tilray has rallied as much as 470%. In fact, at one point, it nearly gave Canopy Growth a run for its money as the largest marijuana stock by market cap. [Read More @ Motley Fool]
About The Author:
Credit:Source link